CIK: 0002026172
Total reported value
$587.7M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | Stock-Healthcare | 10.81% | +0.57% | -8.97% | |
| 2 | AMGN | Amgen INC | Stock-Healthcare | 9.71% | — | -26.51% | |
| 3 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 7.25% | -0.64% | EXIT | |
| 4 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 4.99% | -1.32% | -2.29% | |
| 5 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 4.37% | — | +64.08% | |
| 6 | TGTX | Tg Therapeutics INC | Stock-Healthcare | 4.07% | — | +78.68% | |
| 7 | NBIX | Neurocrine Biosciences INC | Stock-Healthcare | 3.60% | — | +51.08% | |
| 8 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 3.23% | — | +264.77% | |
| 9 | RVMD | Revolution Medicines INC | Stock-Healthcare | 3.13% | +2.90% | — | |
| 10 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 2.53% | -5.25% | EXIT | |
| 11 | CORT | Corcept Therapeutics INC | Stock-Healthcare | 2.24% | — | -47.32% | |
| 12 | APGE | Apogee Therapeutics INC | Stock-Other | 2.21% | +0.45% | +0.34% | |
| 13 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 2.10% | — | -61.23% | |
| 14 | PCVX | Vaxcyte INC | Stock-Other | 1.96% | +0.59% | +37.71% | |
| 15 | BBIO | Bridgebio Pharma INC | Stock-Healthcare | 1.73% | -4.32% | — | |
| 16 | MRNA | Moderna INC | Stock-Healthcare | 1.70% | +1.38% | NEW | |
| 17 | ALT | Altimmune INC | Stock-Other | 1.69% | — | +242.48% | |
| 18 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 1.66% | — | — | |
| 19 | VKTX | Viking Therapeutics INC | Stock-Healthcare | 1.59% | -1.58% | +28.13% | |
| 20 | SPRY | Ars Pharmaceuticals INC | Stock-Other | 1.49% | — | — | |
| 21 | PFE | Pfizer INC | Stock-Healthcare | 1.48% | — | -77.78% | |
| 22 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 1.36% | — | — | |
| 23 | COGT | Cogent Biosciences INC | Stock-Other | 1.31% | +1.30% | +1.16% | |
| 24 | PTGX | Protagonist Therapeutics INC | Stock-Other | 1.28% | — | — | |
| 25 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 1.24% | — | +2.00% | |
| 26 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 1.12% | — | +29.63% | |
| 27 | RXRX | Recursion Pharmaceuticals-a | Stock-Healthcare | 1.08% | -0.52% | EXIT | |
| 28 | GILD | Gilead Sciences INC | Stock-Healthcare | 1.01% | — | — | |
| 29 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.00% | — | -51.35% | |
| 30 | IMCR | Immunocore Holdings Plc-adr | Stock-Other | 1.00% | +0.57% | +7.63% | |
| 31 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 0.90% | -2.03% | EXIT | |
| 32 | SCPH | Scpharmaceuticals INC | Stock-Other | 0.82% | — | — | |
| 33 | SMMT | Summit Therapeutics INC | Stock-Other | 0.81% | — | +408.63% | |
| 34 | ✓ | Reviva Pharmaceutcls Hldgs I | Stock-Other | 0.78% | — | +935.07% | |
| 35 | ZYME | Zymeworks INC | Stock-Other | 0.69% | -0.58% | — | |
| 36 | SRRK | Scholar Rock Holding CORP | Stock-Other | 0.68% | — | +8.64% | |
| 37 | 2662247D | Iteos Therapeutics INC | Stock-Other | 0.63% | — | — | |
| 38 | URGN | UroGen Pharma Ltd. | Stock-Other | 0.63% | — | +96.80% | |
| 39 | MLTX | Moonlake Immunotherapeutics | Stock-Other | 0.59% | — | — | |
| 40 | MNKD | Mannkind CORP | Stock-Other | 0.59% | -0.75% | — | |
| 41 | ACAD | Acadia Pharmaceuticals INC | Stock-Healthcare | 0.58% | — | — | |
| 42 | VRDN | Viridian Therapeutics INC | Stock-Other | 0.52% | — | -24.68% | |
| 43 | MRK | Merck & Co. INC. | Stock-Healthcare | 0.48% | +2.05% | NEW | |
| 44 | 430 | Terns Pharmaceuticals INC | Stock-Other | 0.48% | -1.23% | +650.03% | |
| 45 | QURE | uniQure N.V. | Stock-Other | 0.44% | — | -45.38% | |
| 46 | BHVN | Biohaven Ltd. | Stock-Other | 0.43% | — | — | |
| 47 | PCRX | Pacira Biosciences INC | Stock-Other | 0.43% | — | +51.38% | |
| 48 | OCUL | Ocular Therapeutix INC | Stock-Other | 0.39% | -1.14% | EXIT | |
| 49 | OLMA | Olema Pharmaceuticals INC | Stock-Other | 0.33% | — | +153.66% | |
| 50 | CAPR | Capricor Therapeutics INC | Stock-Other | 0.32% | +2.01% | +251.82% |